Literature DB >> 34216209

Spatiotemporal Analysis of the Association Between Pain Management Clinic Laws and Opioid Prescribing and Overdose Deaths.

Magdalena Cerdá, Katherine Wheeler-Martin, Emilie Bruzelius, William Ponicki, Paul Gruenewald, Christine Mauro, Stephen Crystal, Corey S Davis, Katherine Keyes, Deborah Hasin, Kara E Rudolph, Silvia S Martins.   

Abstract

Pain management clinic (PMC) laws were enacted by 12 states to promote appropriate opioid prescribing, but their impact is inadequately understood. We analyzed county-level opioid overdose deaths (National Vital Statistics System) and patients filling long-duration (≥30 day) or high-dose (≥90 morphine milligram equivalents per day) opioid prescriptions (IQVIA, Inc.) in the United States in 2010-2018. We fitted Besag-York-Mollié spatiotemporal models to estimate annual relative rates (RRs) of overdose and prevalence ratios (PRs) of high-risk prescribing associated with any PMC law and 3 provisions: payment restrictions, site inspections, and criminal penalties. Laws with criminal penalties were significantly associated with reduced PRs of long-duration and high-dose opioid prescriptions (adjusted PR = 0.82, 95% credible interval (CrI): 0.82, 0.82, and adjusted PR = 0.73, 95% CI: 0.73, 0.74 respectively) and reduced RRs of total and natural/semisynthetic opioid overdoses (adjusted RR = 0.86, 95% CrI: 0.80, 0.92, and adjusted RR = 0.84, and 95% CrI: 0.77, 0.92, respectively). Conversely, PMC laws were associated with increased relative rates of synthetic opioid and heroin overdose deaths, especially criminal penalties (adjusted RR = 1.83, 95% CrI: 1.59, 2.11, and adjusted RR = 2.59, 95% CrI: 2.22, 3.02, respectively). Findings suggest that laws with criminal penalties were associated with intended reductions in high-risk opioid prescribing and some opioid overdoses but raise concerns regarding unintended consequences on heroin/synthetic overdoses.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  analgesics; heroin; opioid; pain clinics

Mesh:

Substances:

Year:  2021        PMID: 34216209      PMCID: PMC8796812          DOI: 10.1093/aje/kwab192

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   5.363


  29 in total

1.  Prescription Drug Abuse & Diversion: Role of the Pain Clinic.

Authors:  Khary K Rigg; Samantha J March; James A Inciardi
Journal:  J Drug Issues       Date:  2010

2.  Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.

Authors:  Hude Quan; Bing Li; L Duncan Saunders; Gerry A Parsons; Carolyn I Nilsson; Arif Alibhai; William A Ghali
Journal:  Health Serv Res       Date:  2008-08       Impact factor: 3.402

3.  More States Should Regulate Pain Management Clinics to Promote Public Health.

Authors:  Lainie Rutkow; Jon S Vernick; G Caleb Alexander
Journal:  Am J Public Health       Date:  2017-02       Impact factor: 9.308

4.  Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study.

Authors:  S C Brighthaupt; E M Stone; L Rutkow; E E McGinty
Journal:  Prev Med       Date:  2019-05-29       Impact factor: 4.018

Review 5.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

6.  Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates.

Authors:  Deborah Dowell; Kun Zhang; Rita K Noonan; Jason M Hockenberry
Journal:  Health Aff (Millwood)       Date:  2016-10-01       Impact factor: 6.301

Review 7.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

8.  Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses.

Authors:  Magdalena Cerdá; William R Ponicki; Nathan Smith; Ariadne Rivera-Aguirre; Corey S Davis; Brandon D L Marshall; David S Fink; Stephen G Henry; Alvaro Castillo-Carniglia; Garen J Wintemute; Andrew Gaidus; Paul J Gruenewald; Silvia S Martins
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

9.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

10.  The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt; Steven P Kurtz
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

View more
  4 in total

1.  When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws.

Authors:  Kara E Rudolph; Catherine Gimbrone; Ellicott C Matthay; Iván Díaz; Corey S Davis; Katherine Keyes; Magdalena Cerdá
Journal:  Epidemiology       Date:  2022-06-24       Impact factor: 4.860

2.  Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.

Authors:  Emma E McGinty; Mark C Bicket; Nicholas J Seewald; Elizabeth A Stuart; G Caleb Alexander; Colleen L Barry; Alexander D McCourt; Lainie Rutkow
Journal:  Ann Intern Med       Date:  2022-03-15       Impact factor: 51.598

3.  Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018.

Authors:  Lauren R Gorfinkel; Deborah Hasin; Andrew J Saxon; Melanie Wall; Silvia S Martins; Magdalena Cerdá; Katherine Keyes; David S Fink; Salomeh Keyhani; Charles C Maynard; Mark Olfson
Journal:  J Pain       Date:  2022-02-08       Impact factor: 5.383

4.  The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic.

Authors:  Elizabeth D Nesoff; Megan E Marziali; Silvia S Martins
Journal:  Addiction       Date:  2021-12-27       Impact factor: 7.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.